@prefix dcterms:  .
@prefix this:  .
@prefix sub:  .
@prefix beldoc:  .
@prefix rdfs:  .
@prefix rdf:  .
@prefix xsd:  .
@prefix dce:  .
@prefix pav:  .
@prefix np:  .
@prefix belv:  .
@prefix prov:  .
@prefix go:  .
@prefix RNA:  .
@prefix hgnc:  .
@prefix geneProductOf:  .
@prefix obo:  .
@prefix occursIn:  .
@prefix species:  .
@prefix pubmed:  .
@prefix orcid:  .
sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}
sub:assertion {
  sub:_1 geneProductOf: hgnc:1579;
    a RNA: .
  
  sub:_2 occursIn: obo:CLO_0003684, species:9606;
    rdf:object sub:_1;
    rdf:predicate belv:increases;
    rdf:subject go:0000085;
    a rdf:Statement .
  
  sub:assertion rdfs:label "bp(GOBP:\"mitotic G2 phase\") -> r(HGNC:CCNB1)" .
}
sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_4;
    pav:version "20131211" .
  
  sub:_3 prov:value "Table I Genes with G2/M-specific and DNA damage-responsive expression: The relative increase in expression during G2 (as compared with S phase, i.e. at 7 h after release when compared with 1 h after release) is indicated in the third and fourth columns, and the average of these two independent analyses are in boldface type in the fifth column. ";
    prov:wasQuotedFrom pubmed:11483598 .
  
  sub:_4 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:11483598;
    prov:wasDerivedFrom beldoc:, sub:_3 .
}
sub:pubinfo {
  this: dcterms:created "2014-07-03T14:31:42.922+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}